Stock ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Eli Lilly and Company Lima

Equities

US5324571083

End-of-day quote Lima
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
903.6 USD -.--% Intraday chart for Eli Lilly and Company -0.03% -.--%
01/07 Eli Lilly, Radionetics Oncology Strike Strategic Agreement MT
01/07 Sanofi eyes German insulin investment of up to $1.6 bln, source says RE

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Eli Lilly, Radionetics Oncology Strike Strategic Agreement
Sanofi eyes German insulin investment of up to $1.6 bln, source says
'HB': Sanofi plant Milliarden-Investition in Frankfurt
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Tesla to Advance, Nvidia to Decline
Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older
India plans incentives for diabetes, obesity drug makers in 2026, government official says
Vendedores en corto sobre Nvidia, ganadores son ganadores y baby blues
Le bric-à-brac de Zonebourse : VAD sur Nvidia, les gagnants sont les gagnants et baby blues
Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls
Eli Lilly Teams Up With OpenAI to Develop Antimicrobials for Drug-Resistant Bacteria
Eli Lilly : accord de collaboration avec OpenAI
Novo Nordisk auf Rekordhoch - erstmals über 1000 dänische Kronen
Eli Lilly and : s'allie à OpenAI contre la résistance aux antimicrobiens
RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU : Capri Holdings, Adobe, Broadcom, Celanese, Admiral...
Novo Nordisk : La Chine approuve le Wegovy pour la perte de poids
Novo Nordisk, fabricante de Wegovy, invertirá 4.100 millones de dólares en impulsar fabricación en EEUU
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing
Doctors must keep Ozempic prescriptions in check, Danish regulator says
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Stock
  5. News Eli Lilly and Company
  6. Other languages